Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
J Orofac Pain ; 26(1): 7-16, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22292135

RESUMO

AIMS: To assess the biopsychosocial factors associated with acute temporomandibular disorders (TMD) based on the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD). METHODS: Participants were assessed in community-based dental clinics and evaluated by trained clinicians using physical and psychosocial measures. A total of 207 subjects were evaluated. Patients' high-risk versus low-risk status for potentially developing chronic TMD was also determined. Analyses of variance and chi square analyses were applied to these data. RESULTS: Participants' characteristic pain intensity differed among RDC/TMD Axis I diagnoses. They also significantly varied in their self-reported graded chronic pain, depression, somatization (pain inclusive), somatization (pain excluded), and physical well-being. In addition, participants with differing RDC/TMD Axis I diagnoses varied in self-reported pain during their chewing performance. Finally, there were also significant differences in chewing performance between high-risk versus low-risk (for developing chronic TMD) patients. CONCLUSION: Participants with multiple diagnoses reported higher pain, as well as other symptoms, relative to participants without a TMD diagnosis. For chewing performance, participants with mutual diagnoses reported more pain compared to other participants. Finally, the risk-status of patients significantly affected chewing performance.


Assuntos
Transtornos da Articulação Temporomandibular/psicologia , Doença Aguda , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Artralgia/fisiopatologia , Artralgia/psicologia , Artrite/fisiopatologia , Artrite/psicologia , Doença Crônica , Dor Crônica/psicologia , Estudos de Coortes , Depressão/psicologia , Dor Facial/classificação , Dor Facial/fisiopatologia , Dor Facial/psicologia , Feminino , Nível de Saúde , Humanos , Luxações Articulares/fisiopatologia , Luxações Articulares/psicologia , Masculino , Mastigação/fisiologia , Músculos da Mastigação/fisiopatologia , Pessoa de Meia-Idade , Osteoartrite/fisiopatologia , Osteoartrite/psicologia , Medição da Dor/métodos , Medição de Risco , Autorrelato , Transtornos Somatoformes/fisiopatologia , Transtornos Somatoformes/psicologia , Disco da Articulação Temporomandibular/fisiopatologia , Transtornos da Articulação Temporomandibular/classificação , Transtornos da Articulação Temporomandibular/fisiopatologia , Adulto Jovem
2.
J Pediatr Gastroenterol Nutr ; 52(3): 319-25, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21336156

RESUMO

OBJECTIVES: We assessed the efficacy of a novel quadruple sequential 10-day eradication therapy, its compliance, and reported adverse events in a sample of asymptomatically Helicobacter pylori-infected children in El Paso, Texas, as part of a study aiming to assess the influence of this infection on the levels of markers of iron stores. PATIENTS AND METHODS: Using a double-blind randomized trial design, 110 asymptomatic children ages 3 to 11 with H pylori infection were randomly assigned to receive either a 10-day course of sequential eradication therapy plus 6 weeks of iron supplementation, eradication therapy plus placebo, iron supplementation plus placebo, or placebo only. H pylori infection status was assessed ≥45 days after treatment using the urea breath test. Analyses compared the proportion of subjects cured according to assignment to and completion of the sequential eradication therapy. RESULTS: Intent-to-treat and per-protocol analyses indicated that 44.3% and 52.9%, respectively, of the children receiving the novel quadruple sequential therapy had their infection eradicated compared with 12.2% and 15.4% in the arms receiving iron or placebo only, respectively (P < 0.001 in both analyses). Study medications were taken with no or only mild adverse events in most children. CONCLUSIONS: A quadruple sequential regimen eradicated H pylori in only half the asymptomatic children receiving this treatment. There was no difference in the cure rates of those receiving iron supplementation and those receiving placebo.


Assuntos
Antibacterianos/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Antibacterianos/farmacologia , Criança , Pré-Escolar , Suplementos Nutricionais , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Infecções por Helicobacter/microbiologia , Humanos , Análise de Intenção de Tratamento , Ferro da Dieta/farmacologia , Masculino , Texas , Resultado do Tratamento
3.
J Pediatr Gastroenterol Nutr ; 52(3): 326-32, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21336159

RESUMO

OBJECTIVES: We assessed whether Helicobacter pylori eradication was followed by changes in iron stores among non-iron-deficient children. MATERIALS AND METHODS: Double-blind randomized intervention trial on 110 asymptomatic 3- to 10-year-olds with H pylori infection assigned to any of the following 4 arms: both quadruple eradication and iron supplementation, either quadruple sequential eradication or iron supplementation, or placebo only. Hemoglobin, transferrin saturation, and serum ferritin were measured at baseline and 8 months later to assess changes according to study arm, H pylori infection status at ≥45 days, and cytotoxin-associated gene product A status. RESULTS: Intent-to-treat (n = 110) and per-protocol (n = 90) analyses revealed no differences across study arms in changes of iron stores. However, we found that those who had their infection eradicated had a 3-fold increased average change from baseline serum ferritin compared with that of children who remained infected (P < 0.05). Eradication of infection by cytotoxin-associated gene product A negative strains was associated with a larger ferritin increase. CONCLUSIONS: In this double-blind randomized trial, the first among non-iron-deficient, asymptomatic H pylori-infected children living in the contiguous United States, we found no effect of H pylori eradication regarding changes in iron stores. However, those who had their infection eradicated at follow-up had a significantly larger increase in serum ferritin from baseline.


Assuntos
Antibacterianos/farmacologia , Ferritinas/sangue , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , Ferro da Dieta/farmacologia , Anemia Ferropriva/sangue , Anemia Ferropriva/etiologia , Antibacterianos/uso terapêutico , Biomarcadores/sangue , Criança , Pré-Escolar , Suplementos Nutricionais , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Infecções por Helicobacter/sangue , Infecções por Helicobacter/complicações , Helicobacter pylori/classificação , Humanos , Análise de Intenção de Tratamento , Masculino , Valores de Referência , Especificidade da Espécie , Resultado do Tratamento
4.
Gac méd espirit ; 8(3)sept.-dic. 2006. ilus
Artigo em Espanhol | CUMED | ID: cum-34848

RESUMO

Se realiza una investigación sobre el fotoenvejecimiento prematuro. El fotoenvejecimiento, cada vez adquiere mayor interés científico como causante del envejecimiento prematuro, ya que provoca entre otras alteraciones, la aparición de arrugas, trastornos de la pigmentación y pérdida del tono normal. En algunos estudios se le da importancia a la teoría de que la exposición a la luz solar es responsable del 80 al 90 por ciento del envejecimiento facial


Assuntos
Humanos , Envelhecimento da Pele , Luz Solar/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA